COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2018$904,000
-12.0%
11,190
-8.6%
0.12%
-15.4%
Q4 2017$1,027,000
+15.8%
12,238
+18.4%
0.14%
+16.2%
Q3 2017$887,000
-32.4%
10,334
-34.3%
0.12%
-29.9%
Q2 2017$1,312,000
+16.3%
15,722
+3.4%
0.17%
+16.0%
Q1 2017$1,128,000
+14.3%
15,200
+12.1%
0.14%
+63.6%
Q4 2016$987,000
-9.8%
13,560
-2.1%
0.09%
+2.3%
Q3 2016$1,094,000
-3.0%
13,856
+1.3%
0.09%
+2.4%
Q2 2016$1,128,000
+17.0%
13,678
+2.7%
0.08%
+21.7%
Q1 2016$964,000
-10.7%
13,318
+6.2%
0.07%
-8.0%
Q4 2015$1,079,000
-12.5%
12,542
-6.6%
0.08%
-12.8%
Q3 2015$1,233,000
-14.0%
13,424
-8.0%
0.09%
-3.4%
Q2 2015$1,434,000
+6.1%
14,588
+6.3%
0.09%
+23.6%
Q1 2015$1,352,000
-53.8%
13,720
-56.6%
0.07%
-52.3%
Q4 2014$2,926,000
-26.8%
31,588
-25.7%
0.15%
-26.0%
Q3 2014$4,000,000
+10.8%
42,502
+6.6%
0.20%
+22.2%
Q2 2014$3,611,000
+265.5%
39,888
+243.2%
0.17%
+288.4%
Q1 2014$988,000
-36.3%
11,622
-39.8%
0.04%
-34.8%
Q4 2013$1,552,000
-40.5%
19,314
-43.2%
0.07%
-43.1%
Q3 2013$2,609,000
-15.4%
34,018
-22.0%
0.12%
-20.5%
Q2 2013$3,085,000
+1.4%
43,640
+2.2%
0.15%
+0.7%
Q1 2013$3,042,00042,7120.14%
Other shareholders
NOVARTIS A G shareholders Q3 2014
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders